Zymeworks Insider Spotlight: Catalysts Ahead News ad
Key Points Insider EcoR1 Capital is buying more Zymeworks shares ahead of expected catalysts in 2025. The leading candidate’s approval is expected to expand. The company is well capitalized and can sustain its operations until revenue streams are established. Zymeworks (NYSE: ZYME) came into the spotlight in late December when major … Read more
